Doctor of Osteopathy Program year 2021 Reported 2019–2021 Source: CMS Open Payments, 2026 publication

Ashvin Garlapati

Dermatology Crown Point, IN Doctor of Osteopathy

NPI 1417246851 CMS profile 1321507

70 W 94Th Pl, Crown Point, IN 46307

Open in the dashboard

General payments

$12,281

185 records reported · program years 2019–2021

Research payments

$0

Paid to them · None reported · program years 2019–2021

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$157,964 paid to institutions, not to them · program years 2019–2021

Through program year 2021, Ashvin Garlapati of Crown Point, IN is reported in the CMS Open Payments database as having received $12,281 across 185 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $157,964 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 83rd percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

3 rows
Year Kind Relative to this record's peak year Amount Records
2021 General $653 39
2020 General $5,053 51
2019 General $6,575 95

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ashvin Garlapati
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Ashvin Garlapati were reported at $0. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Ashvin Garlapati Dermatology median Middle half National median
2019 $6,575 $454 $129–$1,240 $163
2020 $5,053 $235 $81–$756 $114
2021 $653 $377 $108–$1,108 $132
2022 $0 $514 $143–$1,391 $149
2023 $0 $607 $159–$1,674 $160
2024 $0 $751 $204–$1,903 $164
2025 $0 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2021
  1. Pfizer Inc. $6,204 28 payments
  2. E.R. Squibb & Sons, L.L.C. $3,360 1 payment
  3. Janssen Biotech, Inc. $512 28 payments
  4. AbbVie, Inc. $490 30 payments
  5. Novartis Pharmaceuticals Corporation $243 12 payments
  6. Regeneron Healthcare Solutions, Inc. $200 9 payments
  7. Galderma Laboratories, L.P. $161 9 payments
  8. Almirall LLC $131 7 payments
  9. Sun Pharmaceutical Industries Inc. $104 7 payments
  10. LEO Pharma Inc. $98 7 payments
  11. Other $777 47 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2021
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $5,975 3 payments
  2. Consulting Fee $3,360 1 payment
  3. Food and Beverage $2,746 178 payments
  4. Education $200 3 payments
Products named General payments · program years 2019–2021
  1. EUCRISA $6,204 28 payments
  2. TREMFYA $408 21 payments
  3. HUMIRA $389 23 payments
  4. SKYRIZI $311 18 payments
  5. STELARA $215 17 payments
  6. DUPIXENT $183 8 payments
  7. EPIDUO FORTE $161 9 payments
  8. COSENTYX $161 8 payments
  9. SOOLANTRA $143 8 payments
  10. Seysara $112 6 payments
  11. Other $1,789 105 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

185 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in Indiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2021

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record